Oxidation Resistance 1 Modulates Glycolytic Pathways in the Cerebellum via an Interaction with Glucose-6-Phosphate Isomerase

[1]  J. Rosenfeld,et al.  Loss of Oxidation Resistance 1, OXR1, Is Associated with an Autosomal-Recessive Neurological Disease with Cerebellar Atrophy and Lysosomal Dysfunction. , 2019, American journal of human genetics.

[2]  K. Davies,et al.  Neuronal over-expression of Oxr1 is protective against ALS-associated mutant TDP-43 mislocalisation in motor neurons and neuromuscular defects in vivo , 2019, Human molecular genetics.

[3]  K. Davies,et al.  Limitations to adaptive homeostasis in an hyperoxia-induced model of accelerated ageing , 2019, Redox biology.

[4]  P. Oliver,et al.  Oxidation resistance 1 regulates post-translational modifications of peroxiredoxin 2 in the cerebellum , 2018, Free radical biology & medicine.

[5]  Y. Ravindranath,et al.  Glucose phosphate isomerase (GPI) Tadikonda: Characterization of a novel Pro340Ser mutation , 2017, Pediatric hematology and oncology.

[6]  P. Gaynon,et al.  Redefining treatment failure for pediatric acute leukemia in the era of minimal residual disease testing , 2017, Pediatric hematology and oncology.

[7]  S. Jacobsen,et al.  Autophagy-Dependent Generation of Free Fatty Acids Is Critical for Normal Neutrophil Differentiation , 2017, Immunity.

[8]  Arun Prakash Upadhyay,et al.  Gp78 E3 Ubiquitin Ligase: Essential Functions and Contributions in Proteostasis , 2017, Front. Cell. Neurosci..

[9]  P. Oliver,et al.  TLDc proteins: new players in the oxidative stress response and neurological disease , 2017, Mammalian Genome.

[10]  Evelyn Rampler,et al.  Anion-Exchange Chromatography Coupled to High-Resolution Mass Spectrometry: A Powerful Tool for Merging Targeted and Non-targeted Metabolomics. , 2017, Analytical chemistry.

[11]  A. Maitra,et al.  Next-generation sequencing unravels homozygous mutation in glucose-6-phosphate isomerase, GPIc.1040G>A (p.Arg347His) causing hemolysis in an Indian infant. , 2017, Clinica chimica acta; international journal of clinical chemistry.

[12]  V. Divoky,et al.  Two novel mutations (p.(Ser160Pro) and p.(Arg472Cys)) causing glucose-6-phosphate isomerase deficiency are associated with erythroid dysplasia and inappropriately suppressed hepcidin. , 2017, Blood cells, molecules & diseases.

[13]  T. Tamiya,et al.  Flow-metabolism uncoupling in the cervical spinal cord of ALS patients , 2017, Neurological Sciences.

[14]  Dima Kozakov,et al.  The ClusPro web server for protein–protein docking , 2017, Nature Protocols.

[15]  Lishan Sun,et al.  Glucose-6-Phosphate Isomerase (G6PI) Mediates Hypoxia-Induced Angiogenesis in Rheumatoid Arthritis , 2017, Scientific Reports.

[16]  Bruno L. Victor,et al.  Hereditary nonspherocytic hemolytic anemia caused by red cell glucose-6-phosphate isomerase (GPI) deficiency in two Portuguese patients: Clinical features and molecular study. , 2016, Blood cells, molecules & diseases.

[17]  A. Matilla-Dueñas,et al.  Ataxin-1 regulates the cerebellar bioenergetics proteome through the GSK3β-mTOR pathway which is altered in Spinocerebellar ataxia type 1 (SCA1). , 2016, Human molecular genetics.

[18]  J. Rosenfeld,et al.  TBC1D24 genotype–phenotype correlation , 2016, Neurology.

[19]  J. Kulisevsky,et al.  Striatal hypometabolism in premanifest and manifest Huntington’s disease patients , 2016, European Journal of Nuclear Medicine and Molecular Imaging.

[20]  K. Davies,et al.  The antioxidant protein Oxr1 influences aspects of mitochondrial morphology , 2016, Free radical biology & medicine.

[21]  K. Davies,et al.  The Evolutionarily Conserved Tre2/Bub2/Cdc16 (TBC), Lysin Motif (LysM), Domain Catalytic (TLDc) Domain Is Neuroprotective against Oxidative Stress* , 2015, The Journal of Biological Chemistry.

[22]  I. Baranowska-Bosiacka,et al.  Energy Metabolism of the Brain, Including the Cooperation between Astrocytes and Neurons, Especially in the Context of Glycogen Metabolism , 2015, International journal of molecular sciences.

[23]  Eoon Hye Ji,et al.  Targeted Metabolomic Analysis of Head and Neck Cancer Cells Using High Performance Ion Chromatography Coupled with a Q Exactive HF Mass Spectrometer. , 2015, Analytical chemistry.

[24]  M. Meng,et al.  A novel binding of GTP stabilizes the structure and modulates the activities of human phosphoglucose isomerase/autocrine motility factor , 2015, Biochemistry and biophysics reports.

[25]  Lishan Sun,et al.  Glucose-6-phosphate isomerase promotes the proliferation and inhibits the apoptosis in fibroblast-like synoviocytes in rheumatoid arthritis , 2015, Arthritis Research & Therapy.

[26]  K. Davies,et al.  Oxr1 improves pathogenic cellular features of ALS-associated FUS and TDP-43 mutations , 2015, Human molecular genetics.

[27]  K. Davies,et al.  Neuron-specific antioxidant OXR1 extends survival of a mouse model of amyotrophic lateral sclerosis , 2015, Brain : a journal of neurology.

[28]  R. Hennekam,et al.  TBC1D24-Related Disorders , 2015 .

[29]  Fabian Sievers,et al.  Clustal Omega , 2014, Current protocols in bioinformatics.

[30]  D. Krainc,et al.  The glycolytic enzyme, GPI, is a functionally conserved modifier of dopaminergic neurodegeneration in Parkinson's models. , 2014, Cell metabolism.

[31]  O. Podhajcer,et al.  Increased Migration of Human Mesenchymal Stromal Cells by Autocrine Motility Factor (AMF) Resulted in Enhanced Recruitment towards Hepatocellular Carcinoma , 2014, PloS one.

[32]  Y. Zhuang,et al.  Performance and Mechanism of Neuroleukin in the Growth and Survival of Sertoli Cell-Induced Neurons in a Coculture System , 2014, Cell transplantation.

[33]  L. Eberly,et al.  Non‐invasive detection of neurochemical changes prior to overt pathology in a mouse model of spinocerebellar ataxia type 1 , 2013, Journal of neurochemistry.

[34]  T. Coates,et al.  Glucose Phosphate Isomerase Deficiency In 2 Patients With Novel Mutations Presenting As Severe Neurologic Abnormalities and Transfusion Dependent Hemolytic Anemia , 2013 .

[35]  Andreas Meisel,et al.  Sugar for the brain: the role of glucose in physiological and pathological brain function , 2013, Trends in Neurosciences.

[36]  I. Nabi,et al.  Raft endocytosis of AMF regulates mitochondrial dynamics through Rac1 signaling and the Gp78 ubiquitin ligase , 2013, Journal of Cell Science.

[37]  K. Ghosh,et al.  Hereditary non-spherocytic hemolytic anemia and severe glucose phosphate isomerase deficiency in an Indian patient homozygous for the L487F mutation in the human GPI gene , 2012, International Journal of Hematology.

[38]  D. Attwell,et al.  Updated Energy Budgets for Neural Computation in the Neocortex and Cerebellum , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[39]  S. Thirup,et al.  Crystal structure of the TLDc domain of oxidation resistance protein 2 from zebrafish , 2012, Proteins.

[40]  A. Chiò,et al.  Brain hypermetabolism in amyotrophic lateral sclerosis: a FDG PET study in ALS of spinal and bulbar onset , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[41]  Pierre J Magistretti,et al.  Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. , 2011, Cell metabolism.

[42]  K. Davies,et al.  Oxr1 Is Essential for Protection against Oxidative Stress-Induced Neurodegeneration , 2011, PLoS genetics.

[43]  B. Sharrack,et al.  Phosphatase and tensin homologue/protein kinase B pathway linked to motor neuron survival in human superoxide dismutase 1-related amyotrophic lateral sclerosis , 2011, Brain : a journal of neurology.

[44]  J. Gécz,et al.  A focal epilepsy and intellectual disability syndrome is due to a mutation in TBC1D24. , 2010, American journal of human genetics.

[45]  K. Bushara,et al.  Neurochemical alterations in spinocerebellar ataxia type 1 and their correlations with clinical status , 2010, Movement disorders : official journal of the Movement Disorder Society.

[46]  Dinesh K. Deelchand,et al.  Noninvasive Detection of Presymptomatic and Progressive Neurodegeneration in a Mouse Model of Spinocerebellar Ataxia Type 1 , 2010, The Journal of Neuroscience.

[47]  P. Boivin,et al.  A new variant of glucosephosphate isomerase deficiency with mild haemolytic anemia (GPI-MYTHO). , 2009, Scandinavian journal of haematology.

[48]  M. Meng,et al.  Effects of inherited mutations on catalytic activity and structural stability of human glucose-6-phosphate isomerase expressed in Escherichia coli. , 2009, Biochimica et biophysica acta.

[49]  Alberto Pupi,et al.  Brain Glucose Hypometabolism and Oxidative Stress in Preclinical Alzheimer's Disease , 2008, Annals of the New York Academy of Sciences.

[50]  Ben M. Webb,et al.  Comparative Protein Structure Modeling Using MODELLER , 2007, Current protocols in protein science.

[51]  G. Brewer,et al.  Isolation and culture of adult neurons and neurospheres , 2007, Nature Protocols.

[52]  W. Shao,et al.  The OXR domain defines a conserved family of eukaryotic oxidation resistance proteins , 2007, BMC Cell Biology.

[53]  B. Oliva,et al.  Red cell glucose phosphate isomerase (GPI): a molecular study of three novel mutations associated with hereditary nonspherocytic hemolytic anemia , 2006, Human mutation.

[54]  Ben M. Webb,et al.  Comparative Protein Structure Modeling Using Modeller , 2006, Current protocols in bioinformatics.

[55]  A. Raz,et al.  Crystal structures of mouse autocrine motility factor in complex with carbohydrate phosphate inhibitors provide insight into structure-activity relationship of the inhibitors. , 2006, Journal of molecular biology.

[56]  B. Oliva,et al.  Glucose phosphate isomerase deficiency: enzymatic and familial characterization of Arg346His mutation. , 2005, Biochimica et biophysica acta.

[57]  A. Raz,et al.  Differential Regulation of Phosphoglucose Isomerase/Autocrine Motility Factor Activities by Protein Kinase CK2 Phosphorylation* , 2005, Journal of Biological Chemistry.

[58]  J. Chirgwin,et al.  The crystal structure of mouse phosphoglucose isomerase at 1.6A resolution and its complex with glucose 6-phosphate reveals the catalytic mechanism of sugar ring opening. , 2004, Journal of molecular biology.

[59]  M. Volkert,et al.  Stress Induction and Mitochondrial Localization of Oxr1 Proteins in Yeast and Humans , 2004, Molecular and Cellular Biology.

[60]  G. Ippolito,et al.  Neuroleukin inhibition sensitises neuronal cells to caspase-dependent apoptosis. , 2003, Biochemical and biophysical research communications.

[61]  G. Oliva,et al.  Crystal structure of human phosphoglucose isomerase and analysis of the initial catalytic steps. , 2003, Biochimica et biophysica acta.

[62]  I. Nabi,et al.  The enzymatic activity of phosphoglucose isomerase is not required for its cytokine function , 2003, FEBS letters.

[63]  A. Raz,et al.  Inhibition mechanism of cytokine activity of human autocrine motility factor examined by crystal structure analyses and site-directed mutagenesis studies. , 2002, Journal of molecular biology.

[64]  W. Shao,et al.  ERAP140, a Conserved Tissue-Specific Nuclear Receptor Coactivator , 2002, Molecular and Cellular Biology.

[65]  M. Ferrone,et al.  The tumor autocrine motility factor receptor, gp78, is a ubiquitin protein ligase implicated in degradation from the endoplasmic reticulum , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[66]  J. Chirgwin,et al.  The crystal structure of human phosphoglucose isomerase at 1.6 A resolution: implications for catalytic mechanism, cytokine activity and haemolytic anaemia. , 2001, Journal of molecular biology.

[67]  D. Housman,et al.  Functional genomics reveals a family of eukaryotic oxidation protection genes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[68]  S. Oliverio,et al.  Early Alterations in Gene Expression and Cell Morphology in a Mouse Model of Huntington's Disease , 2000, Journal of neurochemistry.

[69]  C. Hsiao,et al.  The Crystal Structure of Phosphoglucose Isomerase/Autocrine Motility Factor/Neuroleukin Complexed with Its Carbohydrate Phosphate Inhibitors Suggests Its Substrate/Receptor Recognition* , 2000, The Journal of Biological Chemistry.

[70]  I. Nabi,et al.  Expression of the AMF/neuroleukin receptor in developing and adult brain cerebellum , 2000, Journal of neuroscience research.

[71]  M. Lakomek,et al.  Glucose-6-phosphate isomerase deficiency. , 2000, Bailliere's best practice & research. Clinical haematology.

[72]  G. Petsko,et al.  Crystal structure of rabbit phosphoglucose isomerase, a glycolytic enzyme that moonlights as neuroleukin, autocrine motility factor, and differentiation mediator. , 2000, Biochemistry.

[73]  Y. J. Sun,et al.  The crystal structure of a multifunctional protein: phosphoglucose isomerase/autocrine motility factor/neuroleukin. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[74]  H. Muirhead,et al.  Molecular basis of neurological dysfunction coupled with haemolytic anaemia in human glucose-6-phosphate isomerase (GPI) deficiency , 1998, Human Genetics.

[75]  A. Raz,et al.  Expression and secretion of neuroleukin/phosphohexose isomerase/maturation factor as autocrine motility factor by tumor cells. , 1998, Cancer research.

[76]  L. Forman,et al.  Glucosephosphate isomerase (GPI) deficiency mutations associated with hereditary nonspherocytic hemolytic anemia (HNSHA). , 1997, Blood cells, molecules & diseases.

[77]  M. Lakomek,et al.  Erythrocyte pyruvate kinase- and glucose phosphate isomerase deficiency: perturbation of glycolysis by structural defects and functional alterations of defective enzymes and its relation to the clinical severity of chronic hemolytic anemia. , 1997, Biophysical chemistry.

[78]  A. Zanella,et al.  Study of the molecular defects in glucose phosphate isomerase-deficient patients affected by chronic hemolytic anemia. , 1996, Blood.

[79]  S. Ohga,et al.  Molecular analysis of glucose phosphate isomerase deficiency associated with hereditary hemolytic anemia. , 1996, Blood.

[80]  S. Miwa,et al.  Hematologically important mutations: molecular abnormalities of glucose phosphate isomerase deficiency. , 1996, Blood cells, molecules & diseases.

[81]  T Shinozaki,et al.  Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide. , 1996, Cancer research.

[82]  E. Beutler,et al.  The characterization of gene mutations for human glucose phosphate isomerase deficiency associated with chronic hemolytic anemia. , 1994, The Journal of clinical investigation.

[83]  Y. Mizrachi.  Neurotrophic activity of monomeric glucophosphoisomerase was blocked by human immunodeficiency virus (HIV‐1) and peptides from HIV‐1 envelope glycoprotein , 1989, Journal of neuroscience research.

[84]  V. Cunningham,et al.  Effect of 6‐Phosphogluconate on Phosphoglucose Isomerase in Rat Brain In Vitro and In Vivo , 1989, Journal of neurochemistry.

[85]  F. Sharp,et al.  Regional brain glycogen stores and metabolism during complete global ischaemia. , 1989, Neurological research.

[86]  H. Mohrenweiser,et al.  Characterization of a series of electrophoretic and enzyme activity variants of human glucose-phosphate isomerase , 1987, Human Genetics.

[87]  M. Gurney,et al.  Molecular cloning and expression of neuroleukin, a neurotrophic factor for spinal and sensory neurons. , 1986, Science.

[88]  M. Gahr,et al.  Clinical symptoms and biochemical properties of three new glucosephosphate isomerase variants , 1986, Blut.

[89]  L. Liotta,et al.  Tumor cell autocrine motility factor. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[90]  M. Gahr,et al.  Generalised glucosephosphate isomerase (GPI) deficiency causing haemolytic anaemia, neuromuscular symptoms and impairment of granulocytic function: a new syndrome due to a new stable GPI variant with diminished specific activity (GPI Homburg) , 1985, European Journal of Pediatrics.

[91]  H. Mohrenweiser,et al.  Frequency of thermostability variants: estimation of total "rare" variant frequency in human populations. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[92]  W. Meier-Ruge,et al.  Glycolytic enzymes from human autoptic brain cortex: Normal aged and demented cases , 1980, Mechanisms of Ageing and Development.

[93]  A. Zanella,et al.  The first stable variant of erythrocyte glucose‐phosphate isomerase associated with severe hemolytic anemia , 1980, American journal of hematology.

[94]  L. Eberly,et al.  NONINVASIVE DETECTION OF NEUROCHEMICAL CHANGES PRIOR TO OVERT PATHOLOGY IN A MOUSE MODEL OF SPINOCEREBELLAR ATAXIA TYPE 1 , 2017 .

[95]  L. Cantley,et al.  Diverting Glycolysis to Combat Oxidative Stress , 2015 .

[96]  K. Nakao,et al.  Diverting Glycolysis to Combat Oxidative Stress -- Innovative Medicine: Basic Research and Development , 2015 .

[97]  J. Deitmer,et al.  Higher transport and metabolism of glucose in astrocytes compared with neurons: a multiphoton study of hippocampal and cerebellar tissue slices. , 2014, Cerebral cortex.

[98]  M. Teitell,et al.  Techniques to monitor glycolysis. , 2014, Methods in enzymology.

[99]  Min Wu,et al.  Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells. , 2007, American journal of physiology. Cell physiology.

[100]  T. Arendt,et al.  Activities of key glycolytic enzymes in the brains of patients with Alzheimer's disease , 1999, Journal of Neural Transmission.

[101]  Louis Sokoloff,et al.  Circulation and Energy Metabolism of the Brain , 1999 .

[102]  M. Gahr,et al.  Combination of congenital nonspherocytic haemolytic anaemia and impairment of granulocyte function in severe glucosephosphate isomerase deficiency. A new variant enzyme designated GPI Calden. , 1990, Acta haematologica.

[103]  HighWire Press.  The journal of neuroscience : the official journal of the Society for Neuroscience. , 1981 .

[104]  A. Arnold,et al.  Glucose Phosphate Isomerase Deficiency with Congenital Nonspherocytic Hemolytic Anemia: A New Variant (Type Nordhorn) I. Clinical and Genetic Studies , 1974, Pediatric Research.

[105]  S. Welch.  An immunological approach to the study of inherited differences in the activity of human erythrocyte phosphoglucose isomerase. , 1973, Human heredity.

[106]  J. Rosenfeld,et al.  TBC 1 D 24 genotype – phenotype correlation Epilepsies and other neurologic features , 2022 .